CRANBURY, N.J.--(BUSINESS WIRE)--OncLive®, the leading digital provider of resources and information for oncology professionals, presents the latest Regional Seminar Series on lymphoma. The program will be held June 20 at 6:30 p.m. at Del Frisco’s Grille in Chestnut Hill, Massachusetts.
“This seminar presents an excellent opportunity for clinicians and researchers to share their insights,” said Michael J. Hennessy Jr., president of MJH Associates, Inc, parent company of OncLive®. “We are thrilled to host this program and discuss the significant advances in management and treatment of lymphoma.”
OncLive®’s Regional Seminar Series: Lymphoma is a 3-hour dinner meeting offering an educational session that will be co-chaired by Eric D. Jacobsen, M.D., clinical director, adult lymphoma program, senior physician. Assistant professor of medicine, Harvard Medical School, director histiocyte disorders center and David C. Fischer, M.D., institute physician, assistant professor of medicine, Harvard Medical School. The program will share insight on the latest research on treatment and management of lymphomas. The presenters will also address audience questions during the question-and-answer session.
“We are delighted to offer such an outstanding educational opportunity to the lymphoma community,” said Robert Goldsmith, vice president of OncLive®. “Through this event, we hope to ignite ideas to offer better care to patients.”
Registration is free and open to all oncology professionals. Complimentary dinner and drinks will also be served. To register or for more information, visit https://www.onclive.com/meetings/regional-seminar-series.
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for MJH Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.